Novo Nordisk
NVO
#106
Rank
A$269.86 B
Marketcap
A$61.22
Share price
2.09%
Change (1 day)
-20.39%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Quarterly Reports

Thumbnail Novo Nordisk Quarterly Report 2021-q1

Quarterly Report 2021-q1

Language: English

View Quarterly Report
Thumbnail Novo Nordisk Quarterly Report 2020-q1

Quarterly Report 2020-q1

Language: English

View Quarterly Report